MedPath

Assess effect of angiographic embolisation of the tumor vessels (with chemotherapy drug ) and surgery on tumor cells circulating in blood in hepatocellular cancer patients

Not Applicable
Conditions
Health Condition 1: null- Hepatocellular carcinomaHealth Condition 2: C220- Liver cell carcinoma
Registration Number
CTRI/2016/06/007049
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

All patients of HCC deemed resectable based on clinico-radiological criteria with or without histological proof and child-Pugh status after Joint clinic discussion will be counseled for getting enrolled in the study

Following patients with HCC are considered for resection and will be encouraged to participate in the study

Non metastatic HCC in a non cirrhotic or a Childs A cirrhotic patient if adequate FLR future liver remnant can be ensured post resection and if R0 resection can be achieved

Solitary HCC irrespective of the size of the tumor

Low volume disease few lesions up to 4 multicentric disease, localized in one lobe if can be completely resected

Exclusion Criteria

Patients of HCC planned in Joint clinic for treatment options other than Resection

Patients enrolled but intra operatively found to be inoperable

Patients refusing to participate in the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath